Literature DB >> 11092393

Fracture risk among patients with Paget's disease: a population-based cohort study.

L J Melton1, R D Tiegs, E J Atkinson, W M O'Fallon.   

Abstract

Localized disruption of bone architecture leads to an increased risk of pathological fractures in patients with Paget's disease, but the impact of the disease on overall fracture risk is unknown. We addressed this issue among 236 Olmsted County, Minnesota residents (107 women and 129 men) first diagnosed with Paget's disease from 1950 through 1994. These subjects (mean +/- SD age at diagnosis, 69.6+/-12.2 years) were followed subsequently for 2798 person-years. During this period of observation, 33 pathological fractures were attributed to Paget's disease (1 skull, 11 vertebra, 1 shaft/distal humerus, 1 pelvis, 6 proximal femur, 2 shaft/distal femur, and 11 tibia/fibula). Excluding the fractures through pagetic bone, there was no increase in overall fracture risk in this cohort (standardized incidence ratio [SIR], 1.2; 95% CI, 0.9-1.4). However, there was a statistically significant increase in the risk of subsequent vertebra (SIR, 3.0; 95% CI, 2.2-4.1) and rib fractures (SIR, 1.7; 95% CI, 1.1-2.4) but not fractures of the proximal femur (SIR, 0.6; 95% CI, 0.3-1.1) or distal forearm (SIR, 1.4; 95% CI, 0.7-2.5). Thus, unselected patients with Paget's disease in the community, who mostly have mild disease, have a significantly increased risk of vertebral fractures, although this may relate partly to increased surveillance. Additional work is needed to clarify the relationship between Paget's disease and vertebral fractures and to identify individuals at increased risk for more aggressive therapy.

Entities:  

Mesh:

Year:  2000        PMID: 11092393     DOI: 10.1359/jbmr.2000.15.11.2123

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  6 in total

Review 1.  The fracture mechanics of human bone: influence of disease and treatment.

Authors:  Elizabeth A Zimmermann; Björn Busse; Robert O Ritchie
Journal:  Bonekey Rep       Date:  2015-09-02

2.  Prevalence and clinical features of Paget's disease of bone in Japan.

Authors:  Jun Hashimoto; Ikko Ohno; Kiyoshi Nakatsuka; Noriko Yoshimura; Shinjiro Takata; Masaaki Zamma; Hiroo Yabe; Satoshi Abe; Masaki Terada; Kousei Yoh; Masao Fukunaga; Cyrus Cooper; Hirotoshi Morii; Hideki Yoshikawa
Journal:  J Bone Miner Metab       Date:  2006       Impact factor: 2.626

3.  Morbidity and mortality associated with Paget's disease of bone: a population-based study.

Authors:  Robert A Wermers; Robert D Tiegs; Elizabeth J Atkinson; Sara J Achenbach; L Joseph Melton
Journal:  J Bone Miner Res       Date:  2008-06       Impact factor: 6.741

4.  Increase in the Number of Bone Marrow Osteoclast Precursors at Different Skeletal Sites, Particularly in Long Bone and Jaw Marrow in Mice Lacking IL-1RA.

Authors:  Giuliana Ascone; Yixuan Cao; Ineke D C Jansen; Irene Di Ceglie; Martijn H J van den Bosch; Arjen B Blom; Peter L E M van Lent; Vincent Everts; Teun J de Vries
Journal:  Int J Mol Sci       Date:  2020-05-27       Impact factor: 5.923

5.  Zoledronic acid prevents pagetic-like lesions and accelerated bone loss in the p62P394L mouse model of Paget's disease.

Authors:  Anna Daroszewska; Lorraine Rose; Nadine Sarsam; Gemma Charlesworth; Amanda Prior; Kenneth Rose; Stuart H Ralston; Robert J van 't Hof
Journal:  Dis Model Mech       Date:  2018-08-23       Impact factor: 5.758

6.  Paget's Disease and Secondary Hyperparathyroidism: Is Healing Possible?

Authors:  Vincenzo Antonio Panuccio; Rocco Tripepi
Journal:  Front Cell Dev Biol       Date:  2020-05-29
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.